Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 181 results
  • Sort by Sort ascending
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location NCT ID

A Study of the Efficacy and Safety of Zigakibart + Atrasentan in Adult Patients With Primary IgA Nephropathy

IgA Nephropathy (IgAN) Phase3 Australia
Israel
United States

A Study of TRB191 in Patients With Extensive-stage Small Cell Lung Cancer

Extensive-stage Small Cell Lung Cancer Phase1 Israel

A Study to Assess the Safety, Tolerability and Pharmacokinetics of XEP527 in Patients With Stable Schizophrenia

Schizophrenia Phase1 United States

A Study to Investigate the Pharmacokinetics and Safety of PKN605 in Participants With Moderate and Severe Renal Impairment Compared to Matched Control Subjects With Normal Renal Function

Participants With Moderate and Severe Renal Impairment and Healthy Participants Phase1 United States

PULSE Registry: for Patients Receiving Lutetium (177Lu) Vipivotide Tetraxetan

Metastatic Prostate Cancer Switzerland

Pluvicto Real-world Investigation in Survival in Metastatic CRPC

Prostatic Neoplasms, Castration-Resistant, Neoplasm Metastasis United States

A Study of the Safety and Effectiveness of Onasemnogene Abeparvovec (Zolgensma) Intrathecal Injection in Spinal Muscular Atrophy Patients

Spinal Muscular Atrophy Japan

A Real-world Study of the Effectiveness of Angiotensin Receptor-Neprilysin Inhibitor Therapy in Hypertensive Patients in the United Arab Emirates

Hypertension United Arab Emirates

A Study to Explore the Tissue Level Effects of Remibrutinib in Adults With Moderate to Severe HS

Hidradenitis Suppurativa Phase1 United States

A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

Primary IgA Nephropathy Phase3 United States